Trial Profile
Effects of Oxytocin on Familial Interactions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Pervasive child development disorders; Schizophrenia
- Focus Therapeutic Use
- Acronyms DOS
- 04 Dec 2018 Status changed from recruiting to completed.
- 09 Feb 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
- 26 May 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015, according to ClinicalTrials.gov record.